Comparative analysis of B7-1 and B7-2 costimulatory ligands: expression and function.
Open Access
- 1 August 1994
- journal article
- research article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 180 (2) , 631-640
- https://doi.org/10.1084/jem.180.2.631
Abstract
Antigen-specific T cell activation requires the engagement of the T cell receptor (TCR) with antigen as well as the engagement of appropriate costimulatory molecules. The most extensively characterized pathway of costimulation has been that involving the interaction of CD28 and CTLA4 on the T cell with B7 (now termed B7-1) on antigen presenting cells. Recently, B7-2 a second costimulatory ligand for CTLA4, was described, demonstrating the potential complexity of costimulatory interactions. This report examines and compares the expression and function of B7-1 and B7-2. Overall these results indicate that (a) B7-1 and B7-2 can be expressed by multiple cell types, including B cells, T cells, macrophages, and dendritic cells, all of which are therefore candidate populations for delivering costimulatory signals mediated by these molecules; (b) stimulating B cells with either LPS or anti-IgD-dextran induced expression of both B7-1 and B7-2, and peak expression of both costimulatory molecules occurred after 18-42 h of culture. Expression of B7-2 on these B cell populations was significantly higher than expression of B7-1 at all times assayed after stimulation; (c) blocking of B7-2 costimulatory activity inhibited TCR-dependent T cell proliferation and cytokine production, without affecting early consequences of TCR signaling such as induction of CD69 or interleukin 2 receptor alpha (IL-2R alpha); and (d) expression of B7-1 and of B7-2 can be regulated by a variety of stimuli. Moreover, expression of B7-1 and B7-2 can be independently regulated by the same stimulus, providing an additional complexity in the mechanisms available for regulating costimulation and hence immune response.Keywords
This publication has 46 references indexed in Scilit:
- Regulation of immunostimulatory function and costimulatory molecule (B7-1 and B7-2) expression on murine dendritic cells.The Journal of Immunology, 1994
- Evidence for an additional ligand, distinct from B7, for the CTLA-4 receptor.Proceedings of the National Academy of Sciences, 1993
- Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation.Proceedings of the National Academy of Sciences, 1993
- Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens.The Journal of Experimental Medicine, 1986
- The murine IL 2 receptor. I. Monoclonal antibodies that define distinct functional epitopes on activated T cells and react with activated B cells.The Journal of Immunology, 1984
- Strong histocompatibility and cell‐mediated cytotoxic effects of a single Mls difference demonstrated using a new congenic mouse strainEuropean Journal of Immunology, 1983
- ENHANCEMENT OF THE MIXED LYMPHOCYTE-REACTION BY INVIVO TREATMENT OF STIMULATOR SPLEEN-CELLS WITH ANTI-IGD ANTIBODY1983
- B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.The Journal of Immunology, 1982
- Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte Fc receptors.The Journal of Experimental Medicine, 1979
- Mac‐1: a macrophage differentiation antigen identified by monoclonal antibodyEuropean Journal of Immunology, 1979